MEDIA CENTER

Overview

Welcome to the Rockland Technimed Ltd. Media Center, where you can review news, learn about upcoming events and access publications and abstracts related to our Oxy-17® technology platform.

For media inquiries, please contact: media@oxy-17.com

RTL News

Award
Rockland Technimed Ltd has been awarded the Healthcare & Pharmaceutical Awards 2016 for "Best Theranostic Imaging Company 2016 - USA & Most Disruptive Nano-Technology: OxyFusion™"

v5complogos_TCW_2.jpg
Conference link: http://techconnectworld.com/World2016/
"Rockland Technimed, Ltd. ", has been ACCEPTED to SHOWCASE its disruptive Nano-technology OxyFusion™ MRI medium at this year's TechConnect World Innovation Summit & Expo, co-located with the National Innovation Summit and National SBIR/STTR Conference, May 23-25, just outside Washington, D.C., at the Gaylord National Resort & Convention Center, National Harbor, MD.

Rockland Technimed Ltd is a Theranostics company, committed to the early diagnosis and treatment of hypoxic injury. Rockland's disruptive Nano-technology OxyFusion™ MRI medium enriched with its patented Oxy-17® process may set the new Gold standard of Cellular metabolic imaging without radiotracers.
Website: www.oxy-17.com

Hazards of Current Imaging Agent in Use:

Biohazard hazard Reports of Gadolinium:

FDA

Radiological Society of North America

Environmental hazard Reports of Gadolinium:

NIH Report

American Chemical Society

Stanford University


 

Global Regulatory News

 

Publications and Abstracts

Click on this link for Publications & Abstracts in PDF format

PDF Brochure

Click the image to view product brochure

 


ABOUT US
Overview
Management Team
Board of Directors
Scientific Advisory Board


TECHNOLOGY
Introducing OxyFusion®
Theranostics
OxyFusion® Uses
Patient Benefits


PRODUCTS
Oxy Fusion
Oxy Gas
Oxy Water


MEDIA CENTER
Overview
News

Press Releases
Publications & Abstracts


CONTACT US